[HTML][HTML] Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment

MA Hill, SC Gammie - Scientific reports, 2022 - nature.com
Alzheimer's disease (AD) is a complex neurodegenerative disorder that affects multiple
brain regions and is difficult to treat. In this study we used 22 AD large-scale gene …

Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological …

BA Logsdon, TM Perumal, V Swarup, M Wang, C Funk… - BioRxiv, 2019 - biorxiv.org
Alzheimer's disease (AD) is a complex and heterogenous brain disease that affects multiple
inter-related biological processes. This complexity contributes, in part, to existing difficulties …

[HTML][HTML] Genes and pathways underlying regional and cell type changes in Alzheimer's disease

JA Miller, RL Woltjer, JM Goodenbour, S Horvath… - Genome medicine, 2013 - Springer
Abstract Background Transcriptional studies suggest Alzheimer's disease (AD) involves
dysfunction of many cellular pathways, including synaptic transmission, cytoskeletal …

Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms

C Fan, K Chen, J Zhou, P Wong, D He, Y Huang… - Human Genetics, 2021 - Springer
Alzheimer's disease (AD) is one of the most common neurodegeneration diseases caused
by multiple factors. The mechanistic insight of AD remains limited. To disclose molecular …

[HTML][HTML] Co-expression network analysis reveals novel genes underlying Alzheimer's disease pathogenesis

R Hu, Q Yu, S Zhou, Y Yin, R Hu, H Lu… - Frontiers in aging …, 2020 - frontiersin.org
Background: The pathogenesis of Alzheimer's disease (AD) remains to be elucidated. This
study aimed to identify the hub genes in AD pathogenesis and determine their functions and …

AlzBase: an integrative database for gene dysregulation in Alzheimer's disease

Z Bai, G Han, B Xie, J Wang, F Song, X Peng… - Molecular …, 2016 - Springer
Alzheimer's disease (AD) affects a significant portion of elderly people worldwide. Although
the amyloid-β (Aβ) cascade hypothesis has been the prevailing theory for the molecular …

[HTML][HTML] Leveraging existing data sets to generate new insights into Alzheimer's disease biology in specific patient subsets

KD Fowler, JM Funt, MN Artyomov, B Zeskind… - Scientific reports, 2015 - nature.com
To generate new insights into the biology of Alzheimer's Disease (AD), we developed
methods to combine and reuse a wide variety of existing data sets in new ways. We first …

Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis

Y Peng, M Yuan, J Xin, X Liu, J Wang - Bioinformatics, 2020 - academic.oup.com
Motivation Alzheimer's disease (AD) is a serious degenerative brain disease and the most
common cause of dementia. The current available drugs for AD provide symptomatic benefit …

[HTML][HTML] Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach

YS Hu, J Xin, Y Hu, L Zhang, J Wang - Alzheimer's research & therapy, 2017 - Springer
Background Our understanding of the molecular mechanisms underlying Alzheimer's
disease (AD) remains incomplete. Previous studies have revealed that genetic factors …

Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA …

S Barbash, H Soreq - Current Alzheimer Research, 2012 - ingentaconnect.com
End-stage Alzheimer's disease (AD) involves drastic modifications in neuronal molecular
and cellular processes, but little is known about the dynamics of these modifications during …